Selection of induction therapy in kidney transplantation

@article{Hardinger2013SelectionOI,
  title={Selection of induction therapy in kidney transplantation},
  author={K. Hardinger and D. Brennan and C. Klein},
  journal={Transplant International},
  year={2013},
  volume={26}
}
Currently available immunosuppressive agents can be classified into three categories: induction agents, maintenance therapy, and treatment for rejection. This review article will focus on induction immunosuppression. There are three antibodies which are used for induction therapy: the lymphocyte‐depleting agents – anti‐thymocyte globulin and alemtuzumab, and basiliximab which is nondepleting. Historically, immunosuppressant selection was solely based on efficacy for prevention of rejection. In… Expand
Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 101 REFERENCES
INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1
Alemtuzumab induction in renal transplantation.
...
1
2
3
4
5
...